27
Participants
Start Date
March 31, 2015
Primary Completion Date
July 31, 2019
Study Completion Date
March 9, 2022
Regorafenib
Regorafenib 120 mg (3 tablets) each day for 21 days of a 28 day cycle with the possibility of an increase in the dose to 160 mg (4 tablets).
University of Rochester, Rochester
Fox Chase Cancer Center, Philadelphia
University of North Carolina at Chapel Hill, Chapel Hill
Mayo Clinic, Rochester
Collaborators (1)
Bayer
INDUSTRY
University of Rochester
OTHER